Chongqing Zhifei Biological Products Co Ltd
SZSE:300122

Watchlist Manager
Chongqing Zhifei Biological Products Co Ltd Logo
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Watchlist
Price: 27.62 CNY -1.92% Market Closed
Market Cap: 66.3B CNY
Have any thoughts about
Chongqing Zhifei Biological Products Co Ltd?
Write Note

Relative Value

The Relative Value of one Chongqing Zhifei Biological Products Co Ltd stock under the Base Case scenario is 55.55 CNY. Compared to the current market price of 27.62 CNY, Chongqing Zhifei Biological Products Co Ltd is Undervalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
55.55 CNY
Undervaluation 50%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
86
Median 3Y
2.8
Median 5Y
3.7
Industry
7.6
Forward
1.4
vs History
50
vs Industry
10
Median 3Y
13.9
Median 5Y
18.2
Industry
22.1
Forward
9.6
vs History
65
vs Industry
11
Median 3Y
20.2
Median 5Y
32.6
Industry
21.9
vs History
80
vs Industry
3
Median 3Y
32.8
Median 5Y
46.7
Industry
23.4
vs History
95
vs Industry
42
Median 3Y
4.8
Median 5Y
6.2
Industry
2.5
vs History
90
vs Industry
76
Median 3Y
2.7
Median 5Y
3.7
Industry
7.5
Forward
1.4
vs History
85
vs Industry
56
Median 3Y
8.4
Median 5Y
10.5
Industry
9.3
vs History
55
vs Industry
11
Median 3Y
12
Median 5Y
15.4
Industry
4.2
Forward
9.8
vs History
55
vs Industry
9
Median 3Y
12
Median 5Y
15.4
Industry
4
Forward
10.7
vs History
66
vs Industry
11
Median 3Y
19.7
Median 5Y
32.2
Industry
5.9
vs History
53
vs Industry
8
Median 3Y
23.9
Median 5Y
29.4
Industry
3.9
vs History
95
vs Industry
47
Median 3Y
4.4
Median 5Y
5.9
Industry
4.5

Multiples Across Competitors

Competitors Multiples
Chongqing Zhifei Biological Products Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
66.1B CNY 1.8 17.9 15 15
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.3B USD 5.6 61.1 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 4.4 33.5 16 30.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 4.1 915.4 10.2 10.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 9.6 -213.4 21 22.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 5.6 16.6 15.1 16.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
35.8B EUR 19.2 -134.7 -108.7 -79.3
P/S Multiple
Revenue Growth P/S to Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average P/S: 3 457 240.1
1.8
-11%
N/A
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.2
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average P/E: 179.4
17.9
6%
2.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.1
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.5
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
915.4
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -213.4
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -134.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average EV/EBITDA: 16
15
3%
4.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -108.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average EV/EBIT: 20.3
15
-13%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.4
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.1
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.3 N/A N/A

See Also

Discover More
Back to Top